Recombinant Protein Production and Recovery from Bacteria-Derived Vesicles
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:50 min • September 26th, 2025
Begin with a culture of a bacterial species that encodes recombinant proteins tagged with the Vesicle Nucleating Peptide, or VNp, a short peptide that promotes vesicle formation.
Add an inducer to the culture and incubate. The inducer triggers protein expression.
VNp embeds in the inner membrane and promotes membrane curvature, encapsulating the VNp-tagged proteins into budding vesicles.
Transfer the vesicle-rich medium to a tube. Centrifuge it to separate the vesicle-rich supernatant.
Next, filter the supernatant to remove residual contaminants.
Then, pass the filtrate through another membrane filter to capture vesicles on the membrane surface.
Place the membrane in a dish and add phosphate-buffered saline.
Gently detach the vesicles and transfer the suspension into a clean tube.
Sonicate the suspension to disrupt vesicle membranes and release the proteins.
Centrifuge the lysate to separate membrane fragments.
The resulting supernatant contains purified recombinant proteins, ready for analysis.
Induce recombinant protein expression from the T7 promoter by adding IPTG to a final concentration of up to 20 micrograms per milliliter, or 84 micromolar. After allowing sufficient time for induction, pellet the cells by centrifugation at 3000 g and 4 degrees Celsius for 20 minutes. Pass the supernatant through a sterile and detergent free 0.45 micron PES filter to sterilize the vesicle containing media for long-term storage.
To concentrate the vesicles into a smaller volume, pass the sterile vesicle containing media through a sterile and detergent free 0.1 micron MCE filter. Then, gently wash the membrane with 0.5 to 1 milliliters of sterile phosphate buffered saline, or PBS, and use a cell scraper, or plastic spreader to carefully remove vesicles from the membrane. Transfer the vesicle concentrate to a fresh microcentrifuge tube using a pipette.
Purified vesicles can be stored at 4 degrees Celsius. Sonicate the protein containing vesicles in the sterile media using an appropriate schedule to disrupt the vesicular lipid membranes and release protein. Centrifuge the sonicated suspension at 39,000 g and 4 degrees Celsius for 20 minutes to remove the vesicular debris.
Overview
This article describes a method for purifying recombinant proteins using vesicle formation promoted by the Vesicle Nucleating Peptide (VNp). The process involves culturing bacteria, inducing protein expression, and isolating vesicles containing the proteins for further analysis.
Key Study Components
Area of Science
- Biochemistry
- Cell Biology
- Protein Purification
Background
- Recombinant proteins are essential for various biological studies.
- Vesicle formation can aid in the efficient encapsulation of proteins.
- The VNp peptide is known to promote membrane curvature.
- Proper purification techniques are crucial for obtaining functional proteins.
Purpose of Study
- To develop a reliable method for purifying VNp-tagged recombinant proteins.
- To enhance the efficiency of protein extraction from bacterial cultures.
- To provide a protocol that can be used for long-term storage of vesicle-containing media.
Methods Used
- Culturing bacterial species that express VNp-tagged proteins.
- Inducing protein expression using IPTG.
- Centrifugation and filtration to isolate vesicle-rich supernatant.
- Sonication and further centrifugation to obtain purified proteins.
Main Results
- Successful encapsulation of VNp-tagged proteins into vesicles.
- Isolation of a purified supernatant containing recombinant proteins.
- Demonstration of effective vesicle concentration and storage methods.
- Validation of the protocol for future protein analysis.
Conclusions
- The method provides a streamlined approach for protein purification.
- Utilizing VNp enhances the yield of recombinant proteins.
- This protocol can be adapted for various protein types and applications.
Frequently Asked Questions
Executive Industry Relevance
This method enables efficient recovery of recombinant proteins from bacterial vesicles, reducing reliance on cell lysis and associated contaminants. It supports early-stage target validation by providing purified protein for functional assays. The approach enhances predictive confidence in lead identification through scalable, reproducible protein production.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables production of properly folded, vesicle-encapsulated recombinant proteins for target engagement studies.
- Operational Value: Avoids harsh lysis conditions that may compromise protein integrity or introduce confounding factors.
Screening & Assay Development
- Scientific Value: Provides purified protein supernatant suitable for biochemical and binding assays.
- Operational Value: Streamlines protein purification workflow with defined centrifugation and filtration steps.
- Strategic Value: Supports assay standardization by delivering consistent protein quality across experiments.
Translational & Preclinical Research
- Scientific Value: Yields recombinant proteins that can be used to validate target mechanisms in disease-relevant systems.
- Operational Value: Enables long-term storage of vesicle-containing media at 4°C, supporting batch-to-batch consistency.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation to lead identification, where reliable protein supply is essential for downstream screening.
- Discovery Biology: Supports hypothesis testing by providing accessible recombinant protein for functional characterization.
- Screening: Delivers purified protein enabling reproducible compound screening and hit validation.
- Analytics: Generates quantifiable protein outputs suitable for ELISA, SPR, or activity-based assays.
- Enterprise Reuse: Establishes a reusable platform for VNp-tagged protein production across multiple projects.
Operational & Enterprise Impact
- Scientific Value: Increases target validation confidence through access to native-like recombinant protein.
- Operational Value: Improves reproducibility via standardized vesicle isolation and sonication steps.
- Strategic Value: Reduces attrition risk by enabling early functional assessment of targets.
- Portfolio Impact: Facilitates go/no-go decisions based on reliable target engagement data.
Implementation Considerations
- Requires expertise in bacterial culture and inducible expression systems.
- Depends on access to centrifuges, sterile filters, and sonication equipment.
- Necessitates standardized protocols for vesicle detachment and protein release.
- Involves optimization of inducer concentration and incubation time for maximal vesicle yield.
- Limited to proteins compatible with VNp tagging and vesicle encapsulation.
Biopharma FAQs
High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
Related Videos
0 Views
Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System
Related Videos
0 Views
Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
Related Videos
0 Views
A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
Related Videos
0 Views
The MultiBac Protein Complex Production Platform at the EMBL
Related Videos
0 Views
Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
Related Videos
0 Views
High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
Related Videos
0 Views
Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach
Related Videos
0 Views
Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
Related Videos
0 Views
Large-scale Production of Recombinant RNAs on a Circular Scaffold Using a Viroid-derived System in Escherichia coli
Related Videos
0 Views
Last updated: 29 August 2026